152 related articles for article (PubMed ID: 19282832)
1. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
[TBL] [Abstract][Full Text] [Related]
2. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
3. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
5. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Lakhanpal GK; Vecchiarelli-Federico LM; Li YJ; Cui JW; Bailey ML; Spaner DE; Dumont DJ; Barber DL; Ben-David Y
Blood; 2010 Jul; 116(3):428-36. PubMed ID: 20445019
[TBL] [Abstract][Full Text] [Related]
6. The role of Fli-1 in normal cell function and malignant transformation.
Truong AH; Ben-David Y
Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
[TBL] [Abstract][Full Text] [Related]
7. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
8. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
[TBL] [Abstract][Full Text] [Related]
9. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
Ben-David Y; Giddens EB; Letwin K; Bernstein A
Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
[TBL] [Abstract][Full Text] [Related]
12. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
13. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.
Ben-David Y; Giddens EB; Bernstein A
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1332-6. PubMed ID: 2304901
[TBL] [Abstract][Full Text] [Related]
14. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
[TBL] [Abstract][Full Text] [Related]
15. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
16. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
[TBL] [Abstract][Full Text] [Related]
18. Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth.
Ben-David Y; Bani MR; Chabot B; De Koven A; Bernstein A
Mol Cell Biol; 1992 Oct; 12(10):4449-55. PubMed ID: 1406633
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
Myatt SS; Burchill SA
Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
[TBL] [Abstract][Full Text] [Related]
20. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
Darby TG; Meissner JD; Rühlmann A; Mueller WH; Scheibe RJ
Oncogene; 1997 Dec; 15(25):3067-82. PubMed ID: 9444955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
